Home / Research and experimental development on biotechnology (except medical and veterinary science)

BIOGEND THERAPEUTICS PTE. LTD.

Live CompanyUEN 202553378GLocal Company

BIOGEND THERAPEUTICS PTE. LTD. is a local company in Singapore with UEN 202553378G. It was registered on 2 Dec 2025. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202553378G
StatusLive Company
Entity typeLocal Company, Private Company Limited by Shares
Registered2 Dec 2025
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity72106 Research and experimental development on medical and veterinary sciences
Address112 ROBINSON ROAD, #03-01, ROBINSON 112, Singapore 068902
2559 companies at this address
AreaDowntown Core · District 1 (Raffles Place, Cecil, Marina, People's Park)
Nearest stationShenton Way MRT, about 192 m
Officers8

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.